Advancing New Healthcare Solutions Through Collaboration

This month, Johnson & Johnson will return virtually to the BIO-Europe life sciences partnering conference, joining forces with industry experts and emerging innovators to navigate the greatest health challenges of our time. Leading up to the live event, digital partnering opportunities are open for registration and on-demand programming sessions featuring J&J’s leadership will be rolled out to attendees.

Visionaries are invited to submit ideas aiming to improve traditional pill minder design. The innovator(s) with the best idea, technology, or potential solution will receive up to $100,000 in grant funding, access to the global JLABS network and mentorship from experts at the Johnson & Johnson Family of Companies.

In addition to its own cadre of scientists hard at work fighting the pandemic, Johnson & Johnson also supports external researchers and entrepreneurs equally dedicated to finding solutions for the current health crisis. We take a look at some of this groundbreaking work happening across the globe—from San Francisco to Seoul.

Johnson & Johnson Innovation is committed to helping patients, our partners and communities around the world manage the unprecedented impact of COVID-19.